Do CSF biomarkers and FDG PET imaging show sufficient clinical utility for diagnosis of dementia subtypes

During the development of this work, JP was an employee of NICE, which is commissioned and funded by the Department of Health to develop clinical guidelines. No authors received specific funding to write this summary.